找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Central Nervous System Leukemia; Prevention and Treat Renato Mastrangelo,David G. Poplack,Riccardo Ricca Book 1983 Martinus Nijhoff Publish

[复制链接]
查看: 6901|回复: 56
发表于 2025-3-21 18:43:48 | 显示全部楼层 |阅读模式
书目名称Central Nervous System Leukemia
副标题Prevention and Treat
编辑Renato Mastrangelo,David G. Poplack,Riccardo Ricca
视频video
丛书名称Developments in Oncology
图书封面Titlebook: Central Nervous System Leukemia; Prevention and Treat Renato Mastrangelo,David G. Poplack,Riccardo Ricca Book 1983 Martinus Nijhoff Publish
描述In the past 10 to IS years there has been dramatic improvement in the survival of children with acute lymphoblastic leukemia. At the present time, over 50% of children with this disease will be alive and free of their disease at least 5 years from the time of their initial diagnosis. Although a number of factors have contributed to this improvement, perhaps none has been as important as the institution of central nervous system preventive therapy (eNS prophylaxis). However, despite the efficacy of eNS prophylaxis, the prevention and treatment of central nervous system leukemia continues to pose a formidable clinical challenge to the pediatric oncologist. Although successful in most cases, eNS preventive therapy remains ineffective for a small but significant subset of patients at high risk for developing eNS disease. Moreover, it has become increasingly evident that some methods of eNS preventive therapy are associated with long-term, adverse eNS sequelae. Thus, considerable controversy exists regarding the optimal method of eNS prophylaxis. Treatment of the patient who develops overt meningeal leukemia has not been as successful and continues to pose a major clinical challenge. De
出版日期Book 1983
关键词chemotherapy; leukemia; pathology; prevention; radiation therapy
版次1
doihttps://doi.org/10.1007/978-94-009-6708-3
isbn_softcover978-94-009-6710-6
isbn_ebook978-94-009-6708-3
copyrightMartinus Nijhoff Publishers, Boston 1983
The information of publication is updating

书目名称Central Nervous System Leukemia影响因子(影响力)




书目名称Central Nervous System Leukemia影响因子(影响力)学科排名




书目名称Central Nervous System Leukemia网络公开度




书目名称Central Nervous System Leukemia网络公开度学科排名




书目名称Central Nervous System Leukemia被引频次




书目名称Central Nervous System Leukemia被引频次学科排名




书目名称Central Nervous System Leukemia年度引用




书目名称Central Nervous System Leukemia年度引用学科排名




书目名称Central Nervous System Leukemia读者反馈




书目名称Central Nervous System Leukemia读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

1票 100.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 20:20:04 | 显示全部楼层
Central Nervous System Prophylaxis for Therapy of Acute Lymphocytic Leukemia,at cure is now a realistic goal of treatment (1). There has been increasing emphasis in recent years, therefore, on the late consequences of the disease and its therapy. These late consequences include possible organ damage, endocrine dysfunction, second malignancies, central nervous system (CNS) dy
发表于 2025-3-22 01:46:50 | 显示全部楼层
Reduction in Central Nervous System Leukemia with a Pharmaco-kinetically derived Intrathecal-Methot that the primary volume of distribution of IT MTX approximated the extracellular-fluid volume of the central nervous system (CNS) (1). The modified dosage regimen was subsequently confirmed to be less neurotoxic (2), with more consistent cerebrospinal-fluid (CSF) MTX concentrations than dosage base
发表于 2025-3-22 08:05:34 | 显示全部楼层
发表于 2025-3-22 12:18:49 | 显示全部楼层
,Prophylaxis of Central Nervous System Leukaemia: British Experience, 1970–80, the United Kingdom, one of the variables was ‘prophylactic’ treatment against central nervous system (CNS) leukaemia. In view of the overwhelming evidence for the efficacy of such treatment (1, 2), all patients entered to subsequent trials have received some form of CNS prophylaxis. This report com
发表于 2025-3-22 13:29:17 | 显示全部楼层
The Norwegian Methotrexate Study in Childhood Acute Lymphocytic Leukemia,elsewhere in this book, have indicated the potential adverse effects of the combination of cranial irradiation and intrathecal methotrexate. Therefore we have tried to avoid prophylactic cranial irradiation in our treatment protocol.
发表于 2025-3-22 18:14:44 | 显示全部楼层
Therapy Related Central Nervous System Diseases in Children with Acute Lymphocytic Leukemia,nally irradiation to enlarged viscera and mediastinal masses, the majority of children who developed this disease died during the first six months following diagnosis, and rarely did a child survive beyond nine months (1). Farber’s success, reported in 1948, in achieving temporary remissions in five
发表于 2025-3-23 00:18:54 | 显示全部楼层
发表于 2025-3-23 03:21:49 | 显示全部楼层
Evaluation of Adverse Sequelae of Central Nervous System Prophylaxis in Acute Lymphoblastic Leukemin with acute lymphoblastic leukemia. Anatomic abnormalities (defined by CT brain scan), neuroendocrine damage, as well as neurological and intellectual dysfunction have all been reported in patients who have received central nervous system propylaxis, usually in the form of cranial radiation and int
发表于 2025-3-23 09:14:14 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-30 17:26
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表